Tavakolpour S - Search Results

1

A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations.

Piri SM, Edalatfar M, Shool S, Jalalian MN, Tavakolpour S. Piri SM, et al. Among authors: tavakolpour s. Infect Dis (Lond). 2021 May;53(5):315-324. doi: 10.1080/23744235.2020.1871066. Epub 2021 Jan 28. Infect Dis (Lond). 2021. PMID: 33508989 Free PMC article.

2

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.

Tavakolpour S, Darvishi M, Mirsafaei HS, Ghasemiadl M. Tavakolpour S, et al. Infect Dis (Lond). 2018 Feb;50(2):95-106. doi: 10.1080/23744235.2017.1384957. Epub 2017 Oct 11. Infect Dis (Lond). 2018. PMID: 29020844

3

Fatal Outcome of Rituximab in an ANCA Negative Granulomatosis with Polyangiitis Patient with Acute Pancreatitis and Pancreatic Mass.

Alesaeidi S, Hashemi-Amir SY, Piri SM, Tavakolpour S. Alesaeidi S, et al. Among authors: tavakolpour s. Curr Rheumatol Rev. 2021;17(1):2-3. doi: 10.2174/1573397116666200517120935. Curr Rheumatol Rev. 2021. PMID: 32416681 No abstract available.

4

Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.

Rahimi A, Mirzazadeh A, Tavakolpour S. Rahimi A, et al. Among authors: tavakolpour s. Genomics. 2021 Jan;113(1 Pt 2):1221-1232. doi: 10.1016/j.ygeno.2020.09.059. Epub 2020 Sep 30. Genomics. 2021. PMID: 33007398 Free PMC article. Review.

5

The Paradoxical Reaction to Rituximab in Six Granulomatosis with Polyangiitis Patients: How Could it be Explained and Managed?

Alesaeidi S, Piri SM, Tavakolpour S. Alesaeidi S, et al. Among authors: tavakolpour s. Curr Rheumatol Rev. 2021 Aug 30;17(3):327-330. doi: 10.2174/1573397117666210219121659. Curr Rheumatol Rev. 2021. PMID: 33605863

6

The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review.

Habibi MA, Alesaeidi S, Zahedi M, Hakimi Rahmani S, Piri SM, Tavakolpour S. Habibi MA, et al. Among authors: tavakolpour s. Biology (Basel). 2022 Dec 6;11(12):1767. doi: 10.3390/biology11121767. Biology (Basel). 2022. PMID: 36552276 Free PMC article. Review.

7

Pathogenic and protective roles of cytokines in pemphigus: A systematic review.

Tavakolpour S, Mahmoudi H, Mirzazadeh A, Balighi K, Darabi-Monadi S, Hatami S, GhasemiAdl M, Daneshpazhooh M. Tavakolpour S, et al. Cytokine. 2020 May;129:155026. doi: 10.1016/j.cyto.2020.155026. Epub 2020 Feb 10. Cytokine. 2020. PMID: 32058276

8

Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.

Nili A, Farbod A, Neishabouri A, Mozafarihashjin M, Tavakolpour S, Mahmoudi H. Nili A, et al. Among authors: tavakolpour s. Rev Med Virol. 2020 Nov;30(6):1-13. doi: 10.1002/rmv.2133. Epub 2020 Jul 30. Rev Med Virol. 2020. PMID: 33210457 Review.

9

Drug-induced pemphigus: A systematic review of 170 patients.

Ghaedi F, Etesami I, Aryanian Z, Kalantari Y, Goodarzi A, Teymourpour A, Tavakolpour S, Mahmoudi H, Daneshpazhooh M. Ghaedi F, et al. Among authors: tavakolpour s. Int Immunopharmacol. 2021 Mar;92:107299. doi: 10.1016/j.intimp.2020.107299. Epub 2021 Jan 5. Int Immunopharmacol. 2021. PMID: 33418246

10

A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns.

Tavakolpour S, Aryanian Z, Seirafianpour F, Dodangeh M, Etesami I, Daneshpazhooh M, Balighi K, Mahmoudi H, Goodarzi A. Tavakolpour S, et al. Immunopharmacol Immunotoxicol. 2021 Oct;43(5):507-518. doi: 10.1080/08923973.2021.1953063. Epub 2021 Jul 21. Immunopharmacol Immunotoxicol. 2021. PMID: 34287098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters